ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Coffin, McIntosh Named Cancer Society Research Professors

February 11, 1994

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

Funding Opportunities.

March 15, 2002